Haemonetics (NYSE:HAE) Rating Lowered to Buy at StockNews.co

Haemonetics (NYSE:HAE – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Tuesday. A number of other research analysts also recently weighed in on HAE. Barrington Research reduced their target price on shares of Haemonetics from $114.00 to $105.00 and set […]

Related Keywords

United States , , Advisornet Financial Inc , Citigroup , Haemonetics Corporation , Belpointe Asset Management , Barrington Research , Meeder Asset Management Inc , Carmel Capital Partners , Get Free Report , Stock Down , Asset Management , Capital Partners , Net Financial Inc , Haemonetics Daily , Haemonetics , Nyse Hae , Hae , Medical , 40502410 , Downgrade , Stocknews Com ,